A quarter century of advancing treatment for Alzheimer's disease with Leon J. Thal.
Grundman
Michael
M
Alzheimer's Disease Clinical Development Program, Elan Pharmaceuticals, Inc, San Francisco, CA, USA. michael.grundman@elan.com
D000544:Alzheimer Disease / Q000266:history* / Q000628:therapy*; D002986:Clinical Trials as Topic; D049673:History, 20th Century; D049674:History, 21st Century; D006801:Humans